Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant
- 20 August 2007
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 25 (42), 7450-7458
- https://doi.org/10.1016/j.vaccine.2007.08.001
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4+T CellsInfection and Immunity, 2007
- Cloning, Characterization, and Serodiagnostic Evaluation ofLeishmania infantumTandem Repeat ProteinsInfection and Immunity, 2006
- Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasisVaccine, 2006
- A Heterologous Prime‐Boost Vaccination Regimen Using ORFF DNA and Recombinant ORFF Protein Confers Protective Immunity against Experimental Visceral LeishmaniasisThe Journal of Infectious Diseases, 2005
- A role for IgG immune complexes during infection with the intracellular pathogen Leishmania The Journal of Experimental Medicine, 2005
- Cloning of S -Adenosyl- l -Methionine:C-24-Δ-Sterol-Methyltransferase (ERG6) from Leishmania donovani and Characterization of mRNAs in Wild-Type and Amphotericin B-Resistant PromastigotesAntimicrobial Agents and Chemotherapy, 2004
- Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infectionFEMS Immunology & Medical Microbiology, 1998
- Influence of the host and parasite strain in a mouse model of visceralLeishmania infantuminfectionFEMS Immunology & Medical Microbiology, 1998
- Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.The Journal of Experimental Medicine, 1994
- Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.JCI Insight, 1985